Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP107815.RA9kJnlJyE-1MyICyGUGOzg9SXfw9twgYf5n8XnaYg8CU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP107815.RA9kJnlJyE-1MyICyGUGOzg9SXfw9twgYf5n8XnaYg8CU130_assertion type Assertion NP107815.RA9kJnlJyE-1MyICyGUGOzg9SXfw9twgYf5n8XnaYg8CU130_head.
- NP107815.RA9kJnlJyE-1MyICyGUGOzg9SXfw9twgYf5n8XnaYg8CU130_assertion description "[1st report of EREG expression in breast cancer (45.5% of breast cancers studied)/is preferentially expressed in breast tumors co-expressing HER2/HER4.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP107815.RA9kJnlJyE-1MyICyGUGOzg9SXfw9twgYf5n8XnaYg8CU130_provenance.
- NP107815.RA9kJnlJyE-1MyICyGUGOzg9SXfw9twgYf5n8XnaYg8CU130_assertion evidence source_evidence_literature NP107815.RA9kJnlJyE-1MyICyGUGOzg9SXfw9twgYf5n8XnaYg8CU130_provenance.
- NP107815.RA9kJnlJyE-1MyICyGUGOzg9SXfw9twgYf5n8XnaYg8CU130_assertion SIO_000772 17962208 NP107815.RA9kJnlJyE-1MyICyGUGOzg9SXfw9twgYf5n8XnaYg8CU130_provenance.
- NP107815.RA9kJnlJyE-1MyICyGUGOzg9SXfw9twgYf5n8XnaYg8CU130_assertion wasDerivedFrom lhgdn-20090331 NP107815.RA9kJnlJyE-1MyICyGUGOzg9SXfw9twgYf5n8XnaYg8CU130_provenance.
- NP107815.RA9kJnlJyE-1MyICyGUGOzg9SXfw9twgYf5n8XnaYg8CU130_assertion wasGeneratedBy ECO_0000203 NP107815.RA9kJnlJyE-1MyICyGUGOzg9SXfw9twgYf5n8XnaYg8CU130_provenance.